Methylprednisolone induced morning lymphocytosis: A prospective study in patients with immune mediated inflammatory disorders.

MLA

Beniada, Camille, et al. “Methylprednisolone Induced Morning Lymphocytosis: A Prospective Study in Patients with Immune Mediated Inflammatory Disorders.” La Revue de Medecine Interne, vol. 45, no. 10, Oct. 2024, pp. 617–23. EBSCOhost, https://doi.org/10.1016/j.revmed.2024.07.010.

APA

Beniada, C., Couturier, B., Reye, F., Delporte, C., Van Antwerpen, P., De Maertelaer, V., & Cogan, E. (2024). Methylprednisolone induced morning lymphocytosis: A prospective study in patients with immune mediated inflammatory disorders. La Revue de Medecine Interne, 45(10), 617–623. https://doi.org/10.1016/j.revmed.2024.07.010

Chicago

Beniada, Camille, Bruno Couturier, Florence Reye, Cédric Delporte, Pierre Van Antwerpen, Viviane De Maertelaer, and Elie Cogan. 2024. “Methylprednisolone Induced Morning Lymphocytosis: A Prospective Study in Patients with Immune Mediated Inflammatory Disorders.” La Revue de Medecine Interne 45 (10): 617–23. doi:10.1016/j.revmed.2024.07.010.